REDDSTAR is an EU funded project which will develop and test stromal cell therapy to treat for diabetes mellitus. The objective is to control blood glucose while also addressing a range of diabetic complications.


Learn more about the project by visiting our patient publication section.


The REDDSTAR consortium is a network of diabetes specialists, regenerative medicine researchers, biotech industrialists and clinicians, supported by an experienced project management team.


REDDSTAR – Repair of  Diabetic Damage by Stromal Cell Administration

Project Area

Visit this section to find out more about our Project and the innovations and benefits we aim to achieve. We have also included some links to other websites relating to diabetes that may be useful. This section of our website includes information that may be of interest to the general public (our public area).

Scientific Area

Visit this section for technical information relating to our Project including a summary of the phases of the Project, details of Project publications, information about related research and links to relevant policy and legislation.